Defendant
1 case as defendant.
Dolby Laboratories Licensing Corp. is a wholly-owned subsidiary of Dolby Laboratories, Inc., an American technology corporation headquartered in San Francisco, California. Founded in 1965 by Ray Dolby, the parent company, Dolby Laboratories, Inc., is publicly traded on the NYSE under the ticker DLB. As of late 2025 to early 2026, Dolby Laboratories, Inc. employs approximately 2,000 to 2,100 people globally and reported revenues of $1.35 billion for fiscal year 2025, with an anticipated range of $1.4 billion to $1.45 billion for fiscal year 2026.
Dolby Laboratories, Inc. specializes in developing and licensing audio, video, and imaging technologies to enhance entertainment and communication experiences. Its major product lines and technologies, licensed to consumer electronics manufacturers and content creators, include Dolby Digital for audio compression, Dolby Atmos for immersive audio, and Dolby Vision for high-dynamic-range (HDR) video. Dolby Laboratories Licensing Corp. specifically handles the licensing of these patents, often through patent pools, to facilitate the adoption of these technologies across various platforms and devices.
The company's patent litigation posture indicates it is an operating company actively defending its intellectual property. Dolby Laboratories Licensing Corp. has been involved in two tracked cases, appearing once as a plaintiff and once as a defendant, both against Unified Patents, LLC. Unified Patents is a member-based organization focused on deterring non-practicing entity (NPE) patent assertions by challenging patent validity, frequently through Inter Partes Reviews (IPRs) at the Patent Trial and Appeal Board (PTAB).
The tracked cases include "Unified Patents, LLC v. Dolby Laboratories Licensing Corp." at the PTAB in 2020, where Dolby was a defendant, suggesting a challenge to one of its patents. This was followed by "Dolby Laboratories Licensing Corp. v. Unified Patents, LLC" in 2023 at the U.S. Court of Appeals for the Federal Circuit (CAFC), likely an appeal or related action stemming from the PTAB proceedings. This engagement pattern reflects Dolby Laboratories Licensing Corp.'s commitment to protecting its extensive patent portfolio against validity challenges.
The Patent Trial and Appeal Board (PTAB) issued a final written decision finding that Unified Patents failed to show any of the challenged claims (claims 1, 7, and 8) of US10237577 were unpatentable. The Board also declined to adjudicate Dolby's arguments regarding other real parties in interest.